Pear Therapeutics highlighted data today from two studies of a digital cognitive behavioral therapy that acted as the precursor for Somryst, the prescription digital therapeutic for adults with chronic insomnia that was the first to pass through the FDA's Pre-Cert pilot pathway.
The first, a randomized controlled trial of 1,149 Australian adults with insomnia and depressive symptoms, suggested...
The use of cognitive-behavioral therapy interventions, such as Big Health’s Sleepio program, has been found to improve both sleep and mental health in individuals with insomnia and clinically significant depressive symptoms, according to new research published in the Journal of Sleep Research.
Sleepio is a digital sleep-improvement program that offers personalized treatment base on a user’s...
Pear Therapeutics announced this morning that Somryst, its prescription digital therapeutic for adults with chronic insomnia, has received marketing authorization from the FDA.
The treatment provides cognitive behavioral therapy for insomnia (CBTi) alongside personalized, algorithm-generated sleep restriction recommendations. The digital therapeutic was reviewed through the agency's 510(k)...
What happened
A new dual-arm randomized trial published this morning in JAMA Psychiatry found that use of Big Health’s Sleepio app as a digital cognitive behavioral therapy (dCBT) led to significant improvements in self-reported functional health, psychological wellbeing, and sleep-related quality of life among those with symptoms to insomnia.
The trial, which included 1,711 participants...
Physicians have touted the benefits of a good night’s sleep for centuries, if not longer, but it hasn’t been until recent years that a provider can see clear data on whether or not their patients have been hitting the sack.
To investigate whether wearable sleep trackers could play a role in patient-provider conversations, researchers from Indiana University’s Regenstrief Institute have launched a...
ResMed, a medical device company focused on sleep apnea, has launched its first consumer product, a $149 device for tracking and improving sleep called S+. The platform includes a non-contact, cellular-enabled device that uses a motion sensor to detect respiration and movement without touching the body, an app, and a cloud-based analytics engine.
"When we looked at the sleep market, what we...
HealthMap is a previous project from the team now studying sleep health.
Boston Children's Hospital is teaming up with Merck to turn Twitter and Facebook into a new source for sleep health data -- data about how many people in a population suffer from insomnia and what they have in common with each other.
"This is sort of our foray to see how we can mine social media to get an understanding of...
